In addition, Cytimmune Sciences of the United States co-modified recombinant human tumor necrosis factor (rh TNF)-α and sulfhydryl PEG on the surface of gold nanoparticles, and successfully constructed a highly effective anti-tumor drug (113). This evidence concerns the gene TNF and neoplasm.